Nielsen, S. R., Strøbech, J. E., Horton, E. R., Jackstadt, R., Laitala, A., Bravo, M. C., . . . Erler, J. T. (2021). Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade. Nature communications, 12(1), 3414-15. https://doi.org/10.1038/s41467-021-23731-7
Citace podle Chicago (17th ed.)Nielsen, Sebastian R., et al. "Suppression of Tumor-associated Neutrophils by Lorlatinib Attenuates Pancreatic Cancer Growth and Improves Treatment with Immune Checkpoint Blockade." Nature Communications 12, no. 1 (2021): 3414-15. https://doi.org/10.1038/s41467-021-23731-7.
Citace podle MLA (9th ed.)Nielsen, Sebastian R., et al. "Suppression of Tumor-associated Neutrophils by Lorlatinib Attenuates Pancreatic Cancer Growth and Improves Treatment with Immune Checkpoint Blockade." Nature Communications, vol. 12, no. 1, 2021, pp. 3414-15, https://doi.org/10.1038/s41467-021-23731-7.